Global Kinetics Corporation, 31 Queens St., Melbourne 3000, Australia.
Florey Institute of Neuroscience & Mental Health, The University of Melbourne, Parkville 3010, Australia.
Sensors (Basel). 2019 May 15;19(10):2241. doi: 10.3390/s19102241.
Device-assisted therapies (DAT) benefit people with Parkinsons Disease (PwP) but many referrals for DAT are unsuitable or too late, and a screening tool to aid in identifying candidates would be helpful. This study aimed to produce such a screening tool by building a classifier that models specialist identification of suitable DAT candidates. To our knowledge, this is the first objective decision tool for managing DAT referral. Subjects were randomly assigned to either a construction set (n = 112, to train, develop, cross validate, and then evaluate the classifier's performance) or to a test set (n = 60 to test the fully specified classifier), resulting in a sensitivity and specificity of 89% and 86.6%, respectively. The classifier's performance was then assessed in PwP who underwent deep brain stimulation (n = 31), were managed in a non-specialist clinic (n = 81) or in PwP in the first five years from diagnosis (n = 22). The classifier identified 87%, 92%, and 100% of the candidates referred for DAT in each of the above clinical settings, respectively. Furthermore, the classifier score changed appropriately when therapeutic intervention resolved troublesome fluctuations or dyskinesia that would otherwise have required DAT. This study suggests that information from objective measurement could improve timely referral for DAT.
器械辅助治疗 (DAT) 有益于帕金森病患者 (PwP),但许多 DAT 转介并不合适或为时过晚,因此需要一种筛选工具来帮助识别合适的 DAT 候选者。本研究旨在通过构建一个能够模拟专家识别合适 DAT 候选者的分类器来开发这样的筛选工具。据我们所知,这是第一个用于管理 DAT 转介的客观决策工具。研究对象被随机分配到构建集(n = 112,用于训练、开发、交叉验证和评估分类器的性能)或测试集(n = 60,用于测试完全指定的分类器),结果分类器的敏感性和特异性分别为 89%和 86.6%。然后,在接受深部脑刺激的帕金森病患者 (n = 31)、在非专家诊所管理的帕金森病患者 (n = 81) 或在诊断后五年内的帕金森病患者 (n = 22) 中评估分类器的性能。在上述每个临床环境中,分类器分别识别出 87%、92%和 100%的 DAT 转介候选者。此外,当治疗干预解决了可能需要 DAT 的麻烦波动或运动障碍时,分类器评分会适当改变。本研究表明,来自客观测量的信息可以改善 DAT 的及时转介。